| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052561190 |
| P356 | DOI | 10.1038/34657 |
| P3181 | OpenCitations bibliographic resource ID | 4393997 |
| P698 | PubMed publication ID | 9440692 |
| P50 | author | Alberto Bardelli | Q28321691 |
| Paolo M. Comoglio | Q37381902 | ||
| Luca Tamagnone | Q55837455 | ||
| Carla Boccaccio | Q57946610 | ||
| P2093 | author name string | Michieli P | |
| Battistini C | |||
| Andò M | |||
| P2860 | cites work | Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality | Q24685515 |
| Protein modules and signalling networks | Q27860694 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motility | Q28281829 | ||
| A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family | Q28285975 | ||
| Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis | Q28295920 | ||
| Detection of phosphotyrosine-containing proteins in the detergent-insoluble fraction of RSV-transformed fibroblasts by azobenzene phosphonate antibodies | Q28365927 | ||
| Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease | Q29615967 | ||
| Transcriptional responses to polypeptide ligands: the JAK-STAT pathway | Q29620287 | ||
| The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro | Q30450983 | ||
| Motogenic and morphogenic activity of epithelial receptor tyrosine kinases | Q36236949 | ||
| Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression | Q36901389 | ||
| Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor | Q38287574 | ||
| trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation. | Q38342714 | ||
| STATs: signal transducers and activators of transcription | Q40974978 | ||
| Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. | Q41199732 | ||
| Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. | Q41270218 | ||
| Interferon-induced nuclear signalling by Jak protein tyrosine kinases | Q41509404 | ||
| A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor | Q41879451 | ||
| Scatter factor is a fibroblast-derived modulator of epithelial cell mobility | Q42807925 | ||
| Tyrosine kinase receptor indistinguishable from the c-met protein | Q42814654 | ||
| Stat5a is mandatory for adult mammary gland development and lactogenesis. | Q48055024 | ||
| P433 | issue | 6664 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 285-288 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Induction of epithelial tubules by growth factor HGF depends on the STAT pathway | |
| P478 | volume | 391 |
| Q57281072 | A Peptide Representing the Carboxyl-terminal Tail of the Met Receptor Inhibits Kinase Activity and Invasive Growth |
| Q24644379 | A Stat3-interacting protein (StIP1) regulates cytokine signal transduction |
| Q90664296 | A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma |
| Q34661632 | A discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration. |
| Q40224967 | A functional assay for gap junctional examination; electroporation of adherent cells on indium-tin oxide |
| Q45345816 | A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells |
| Q42806275 | A novel mechanism in maggot debridement therapy: protease in excretion/secretion promotes hepatocyte growth factor production |
| Q40179159 | A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma. |
| Q40765252 | A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth |
| Q33869231 | A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. |
| Q36345737 | ADPKD: molecular characterization and quest for treatment |
| Q36949230 | AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival |
| Q47303095 | Activated HGF-c-Met Axis in Head and Neck Cancer |
| Q41624093 | Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma |
| Q39677451 | Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis |
| Q90058426 | Activation of the Met receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro |
| Q36326357 | Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice |
| Q35753150 | Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met. |
| Q32062582 | Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. |
| Q33919595 | Alpha-1 adrenergic receptor transactivates signal transducer and activator of transcription-3 (Stat3) through activation of Src and epidermal growth factor receptor (EGFR) in hepatocytes |
| Q37629131 | Amniotic fluid-borne hepatocyte growth factor protects rat pups against experimental necrotizing enterocolitis |
| Q24633986 | An overview of the c-MET signaling pathway |
| Q58051467 | Analysis of Cellular Proliferation and Survival Signaling by Using Two Ligand/Receptor Systems Modeled by Pathway Logic |
| Q35150379 | Apical surface formation in MDCK cells: regulation by the serine/threonine kinase EMK1. |
| Q40639572 | BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation |
| Q37312433 | Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation |
| Q28085247 | Biology of MET: a double life between normal tissue repair and tumor progression |
| Q30500172 | CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance |
| Q34564103 | Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3. |
| Q42378723 | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers |
| Q26801596 | Chronic inflammation and the development of malignancy in the GI tract |
| Q38302598 | Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells |
| Q64100750 | Comparative STAT3-Regulated Gene Expression Profile in Renal Cell Carcinoma Subtypes |
| Q53426359 | Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis. |
| Q40893206 | Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells |
| Q55191351 | Cross-talk between human airway epithelial cells and 3T3-J2 feeder cells involves partial activation of human MET by murine HGF. |
| Q22254408 | Cross-talk between the proto-oncogenes Met and Ron |
| Q41022590 | Cytoplasmic domains of the human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor beta chain (hbetac) responsible for human GM-CSF-induced myeloid cell differentiation |
| Q28286701 | Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase |
| Q42825226 | Differential requirement of the last C-terminal tail of Met receptor for cell transformation and invasiveness. |
| Q44839303 | Disruption of STAT3 signaling leads to tumor cell invasion through alterations of homotypic cell-cell adhesion complexes |
| Q40877285 | Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells |
| Q34782774 | Drug development of MET inhibitors: targeting oncogene addiction and expedience |
| Q38088774 | Drug discovery using the regulation of gene expression |
| Q34775805 | Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer |
| Q39001792 | Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer |
| Q42443548 | ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis. |
| Q52182757 | Early liver differentiation: genetic potentiation and multilevel growth control. |
| Q54616826 | Effect of sorafenib on murine liver regeneration. |
| Q38112040 | Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension. |
| Q40976813 | Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response |
| Q74586947 | Epidermal growth factor- and hepatocyte growth factor-receptor activity in serum-free cultures of human hepatocytes |
| Q27860487 | Epithelial-mesenchymal transitions in tumour progression |
| Q36095732 | ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis |
| Q51323736 | Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3. |
| Q22253232 | Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation |
| Q40608031 | Evidence for a correlation between trophoblast invasiveness and STAT3 activity |
| Q34783580 | Exocyst is involved in cystogenesis and tubulogenesis and acts by modulating synthesis and delivery of basolateral plasma membrane and secretory proteins |
| Q54563100 | Expression of p53/HGF/c-met/STAT3 signal in fetuses with neural tube defects. |
| Q28213808 | Gab1 phosphorylation: a novel mechanism for negative regulation of HGF receptor signaling |
| Q40609070 | Gene expression alterations during HGF-induced dedifferentiation of a renal tubular epithelial cell line (MDCK) using a novel canine DNA microarray |
| Q39212474 | Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance |
| Q38806819 | Gene of the month: HGF. |
| Q30428825 | Growth factor-eluting cochlear implant electrode: impact on residual auditory function, insertional trauma, and fibrosis |
| Q43737857 | HGF upregulates and modifies subcellular distribution of proteins in colon cancer cell enterocytic differentiation |
| Q28142539 | HGF/SF in mammary epithelial growth and morphogenesis: in vitro and in vivo models |
| Q36027374 | HGF/SF-Met signaling in tumor progression |
| Q28202466 | HGF/SF-met signaling in the control of branching morphogenesis and invasion |
| Q33906033 | HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop |
| Q33565746 | Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target |
| Q40987305 | Hepatocyte growth factor and Madin-Darby canine kidney cells: in vitro models of epithelial cell movement and morphogenesis |
| Q36124924 | Hepatocyte growth factor as potential cardiovascular therapy |
| Q35746501 | Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo |
| Q34972866 | Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail |
| Q38088776 | Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis |
| Q36641404 | Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway |
| Q40644609 | Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via ras mediated pathway |
| Q30414265 | Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition |
| Q33589398 | Hepatocyte growth factor, a versatile signal for developing neurons |
| Q35575126 | Hepatocyte growth factor/scatter factor in development, inflammation and carcinogenesis: its expression and role in oral tissues |
| Q40753421 | Hepatocyte growth factor/scatter factor inhibits UVB-induced apoptosis of human keratinocytes but not of keratinocyte-derived cell lines via the phosphatidylinositol 3-kinase/AKT pathway |
| Q73551263 | Hepatocyte growth factor: a regulator of extracellular matrix genes in mouse mesangial cells |
| Q28217543 | Hepatocyte growth factor: from diagnosis to clinical applications |
| Q38694632 | High glucose induces HGF-independent activation of Met receptor in human renal tubular epithelium |
| Q33314672 | Host-pathogen systems biology: logical modelling of hepatocyte growth factor and Helicobacter pylori induced c-Met signal transduction |
| Q28202069 | Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene |
| Q89231936 | Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma |
| Q35878640 | Implications of TGFβ on Transcriptome and Cellular Biofunctions of Palatal Mesenchyme |
| Q38355005 | In situ electroporation of large numbers of cells using minimal volumes of material |
| Q53362509 | In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy. |
| Q36526999 | Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma. |
| Q38311009 | Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement. |
| Q28253680 | Invasive growth: a MET-driven genetic programme for cancer and stem cells |
| Q34584035 | Invasive growth: from development to metastasis |
| Q36178175 | JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression? |
| Q52318134 | Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy. |
| Q26740512 | Leptin-Induced JAK/STAT Signaling and Cancer Growth |
| Q24291722 | Ligand-regulated binding of FAP68 to the hepatocyte growth factor receptor |
| Q33700482 | Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice |
| Q45318124 | MET activates STAT3 |
| Q37232416 | MET as a target for treatment of chest tumors |
| Q26823626 | MET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysis |
| Q38389999 | MET genetic lesions in non-small-cell lung cancer: pharmacological and clinical implications |
| Q36245150 | MET meet adaptors: functional and structural implications in downstream signalling mediated by the Met receptor |
| Q37427292 | MET pathway as a therapeutic target |
| Q50298129 | MET phosphorylates STAT3 |
| Q38167461 | MET receptor tyrosine kinase as an autism genetic risk factor |
| Q37811895 | MET signalling: principles and functions in development, organ regeneration and cancer |
| Q42809617 | MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential |
| Q38675350 | MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy. |
| Q27008925 | MET: a critical player in tumorigenesis and therapeutic target |
| Q38430194 | MET: a new promising biomarker in non-small-cell lung carcinoma |
| Q39121333 | MET: roles in epithelial-mesenchymal transition and cancer stemness |
| Q34085432 | Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression |
| Q36577128 | Mechanisms of disease: Fibroblasts--a new look at an old problem |
| Q42614278 | Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. |
| Q28140219 | Met receptor tyrosine kinase: enhanced signaling through adapter proteins |
| Q28235183 | Met, metastasis, motility and more |
| Q39978520 | Met-driven invasive growth involves transcriptional regulation of Arhgap12. |
| Q37735617 | MicroRNA-181b-5p, ETS1, and the c-Met pathway exacerbate the prognosis of pancreatic ductal adenocarcinoma after radiation therapy |
| Q40738823 | Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways |
| Q44338350 | Morphine induces mesangial cell proliferation and glomerulopathy via kappa-opioid receptors |
| Q36320552 | Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations. |
| Q36299972 | Mutations of HNF-1beta inhibit epithelial morphogenesis through dysregulation of SOCS-3. |
| Q39979039 | NK3 and NK4 of HGF enhance filamin production via STAT pathway, but not NK1 and NK2 in human breast cancer cells |
| Q24563306 | Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways |
| Q40427081 | Negative feedback regulation of Met-dependent invasive growth by Notch |
| Q64058273 | New Phosphorylation Sites of Rad51 by c-Met Modulates Presynaptic Filament Stability |
| Q34090411 | Nonlinear modelling of cancer: bridging the gap between cells and tumours |
| Q33568923 | Novel MAPK-dependent and -independent tubulogenes identified via microarray analysis of 3D-cultured Madin-Darby canine kidney cells |
| Q47745076 | Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation |
| Q61818040 | Oestrogen inhibits PTPRO to prevent the apoptosis of renal podocytes |
| Q34718156 | Organogenesis: molecular mechanisms of tubulogenesis |
| Q28253621 | PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling |
| Q38846778 | PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells. |
| Q28585618 | PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2 |
| Q39848702 | Palmitoylation regulates the intracellular trafficking and stability of c-Met |
| Q58165232 | Pathway specificity for Met signalling |
| Q50985118 | Physiological Signaling and Structure of the HGF Receptor MET. |
| Q34977988 | Polycystin-1 regulates STAT activity by a dual mechanism |
| Q38007133 | Progress in cancer therapy targeting c-Met signaling pathway |
| Q26773613 | Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics |
| Q54490877 | Proteinase-activated receptor 2 (PAR(2)) in cholangiocarcinoma (CCA) cells: effects on signaling and cellular level. |
| Q36307242 | Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases |
| Q37451569 | Recent perspectives on the genetic background of neural tube defects with special regard to iniencephaly |
| Q36860354 | Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. |
| Q35630528 | Receptor tyrosine kinases and the regulation of macrophage activation |
| Q42796653 | Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis |
| Q24812420 | Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment |
| Q26852136 | Regulation of STATs by polycystin-1 and their role in polycystic kidney disease |
| Q40755904 | Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis |
| Q38134309 | Role of cMET in the development and progression of colorectal cancer |
| Q37190629 | Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration |
| Q28212407 | Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition |
| Q33941404 | Roles of STAT3 defined by tissue-specific gene targeting |
| Q40749632 | SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma. |
| Q39251967 | SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner |
| Q33922381 | STAT family of transcription factors in cytokine-mediated biological responses |
| Q33712802 | STAT signaling in the pathogenesis and treatment of cancer |
| Q38140880 | STAT signaling in the pathogenesis and treatment of myeloid malignancies |
| Q24338667 | STAT1 activation regulates proliferation and differentiation of renal progenitors |
| Q37693272 | STAT1 and pathogens, not a friendly relationship |
| Q24300702 | STAT1 is required for redifferentiation during Madin-Darby canine kidney tubulogenesis |
| Q38671957 | STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications |
| Q36218762 | STAT3 Signaling in Polycystic Kidney Disease |
| Q38310016 | STAT3 and importins are novel mediators of early molecular and cellular responses in experimental duodenal ulceration. |
| Q50298128 | STAT3 binds activated MET receptor |
| Q40032390 | STAT3 regulates ABCA3 expression and influences lamellar body formation in alveolar type II cells |
| Q37550760 | STAT3 regulation of glioblastoma pathogenesis. |
| Q47074089 | STAT3-dependent pathfinding and control of axonal branching and target selection |
| Q39697053 | STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA |
| Q24683896 | Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis |
| Q34632043 | Scatter-factor and semaphorin receptors: cell signalling for invasive growth |
| Q24600230 | Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3 |
| Q40729372 | Sf-Stk kinase activity and the Grb2 binding site are required for Epo-independent growth of primary erythroblasts infected with Friend virus |
| Q30175784 | Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis |
| Q28141139 | Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKL |
| Q27640715 | Solution structure and design of dithiophosphate backbone aptamers targeting transcription factor NF-kappaB |
| Q36734746 | Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking. |
| Q31538849 | Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis. |
| Q42797749 | Src phosphorylates Grb2-associated binder 1 upon hepatocyte growth factor stimulation |
| Q28553147 | Stable Ectopic Expression of ST6GALNAC5 Induces Autocrine MET Activation and Anchorage-Independence in MDCK Cells |
| Q38346379 | Stat-3 is required for pulmonary homeostasis during hyperoxia |
| Q22254226 | Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation |
| Q39951270 | Stat3 is required for the development of skin cancer |
| Q37972656 | Stat3: linking inflammation to (gastrointestinal) tumourigenesis |
| Q33921803 | Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling? |
| Q44066872 | Stimulation of the gastrin-cholecystokinin(B) receptor promotes branching morphogenesis in gastric AGS cells |
| Q97074416 | Structural and Functional Insight Into the Glycosylation Impact Upon the HGF/c-Met Signaling Pathway |
| Q53061725 | Study on the activity of the signaling pathways regulating hepatocytes from G0 phase into G1 phase during rat liver regeneration. |
| Q42425978 | Survival of the weakest: signaling aided by endosomes |
| Q28139783 | Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesis |
| Q52547784 | Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. |
| Q40810405 | Synergistic activity of STAT3 and c-Jun at a specific array of DNA elements in the alpha 2-macroglobulin promoter |
| Q40694894 | Synergistic effect of focal adhesion kinase overexpression and hepatocyte growth factor stimulation on cell transformation |
| Q38770836 | Synergistic effect of pacritinib with erlotinib on JAK2-mediated resistance in epidermal gowth factor receptor mutation-positive non-small cell lung Cancer |
| Q34922227 | Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth |
| Q90292397 | Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges |
| Q27011423 | Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling |
| Q35925127 | Targeting the interleukin-6/Jak/stat pathway in human malignancies |
| Q38239580 | The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms? |
| Q52124884 | The JAK/STAT pathway is required for border cell migration during Drosophila oogenesis. |
| Q33613105 | The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors |
| Q107739555 | The Many Faces of JAKs and STATs Within the COVID-19 Storm |
| Q34170758 | The PTK-STAT signaling pathway has essential roles in T-cell activation in response to antigen stimulation |
| Q38352587 | The Potential of panHER Inhibition in Cancer |
| Q42226560 | The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells. |
| Q39991963 | The Role of Embryonic Stem Cell-expressed RAS (ERAS) in the Maintenance of Quiescent Hepatic Stellate Cells |
| Q40744469 | The SH2-containing inositol 5-phosphatase (SHIP)-1 is implicated in the control of cell-cell junction and induces dissociation and dispersion of MDCK cells |
| Q45286070 | The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading |
| Q24550570 | The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion |
| Q38299420 | The YXXQ motif in gp 130 is crucial for STAT3 phosphorylation at Ser727 through an H7-sensitive kinase pathway |
| Q39736711 | The hepatocyte growth factor isoform NK2 activates motogenesis and survival but not proliferation due to lack of Akt activation |
| Q33922881 | The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation. |
| Q32053890 | The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization |
| Q36843122 | The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. |
| Q33769429 | The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment |
| Q41758116 | The proto-oncogene c-Cbl is a positive regulator of Met-induced MAP kinase activation: a role for the adaptor protein Crk. |
| Q53236761 | The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer. |
| Q38313083 | The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization |
| Q36424002 | The tyrosine kinase sf-Stk and its downstream signals are required for maintenance of friend spleen focus-forming virus-induced fibroblast transformation |
| Q34078075 | Therapeutic applications of transcription factor decoy oligonucleotides |
| Q33293430 | Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice |
| Q39607677 | Transcriptional profiling identifies TNS4 function in epithelial tubulogenesis |
| Q40374481 | Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer. |
| Q33889476 | Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes |
| Q73379080 | Transforming growth factor beta2 inhibition of hepatocyte growth factor-induced endothelial proliferation and migration |
| Q37734455 | Translational therapies for malignant pleural mesothelioma. |
| Q40403957 | Tumor cell pseudopodial protrusions. Localized signaling domains coordinating cytoskeleton remodeling, cell adhesion, glycolysis, RNA translocation, and protein translation |
| Q40626260 | Tyrosine kinase signal specificity: lessons from the HGF receptor |
| Q28577530 | Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions |
| Q36734562 | Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth |
| Q58760425 | Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications |
| Q54500056 | Upregulation of HNF-1β during experimental acute kidney injury plays a crucial role in renal tubule regeneration. |
| Q33645250 | Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells |
| Q39167016 | WKYMVm-induced cross-talk between FPR2 and HGF receptor in human prostate epithelial cell line PNT1A. |
| Q34627068 | What does Stat3 do? |
| Q37207279 | What is New on Thyroid Cancer Biomarkers |
| Q24299786 | Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells |
| Q59810644 | c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types |
| Q50985108 | c-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences |
| Q26775483 | c-Met as a Target for Personalized Therapy |
| Q37651008 | c-Met expression and activity in urogenital cancers - novel aspects of signal transduction and medical implications |
| Q30303932 | c-Src, receptor tyrosine kinases, and human cancer |
| Q38845681 | miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met |
| Q40659196 | p38 MAPK is involved in activin A- and hepatocyte growth factor-mediated expression of pro-endocrine gene neurogenin 3 in AR42J-B13 cells |
Search more.